These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3032560)

  • 1. Symposium on angiotensin-converting enzyme inhibition in cardiac failure. Oslo, 23 October 1985. Proceedings.
    Drugs; 1986; 32 Suppl 5():1-53. PubMed ID: 3032560
    [No Abstract]   [Full Text] [Related]  

  • 2. Converting enzyme inhibition for understanding and management of hypertensive disorders and congestive heart failure. Symposium, Anaheim, California, November 13, 1983.
    Am J Med; 1984 Aug; 77(2A):1-86. PubMed ID: 6089553
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE-inhibition: state of the art. Symposium held during the Xth Congress of the European Society of Cardiology. Vienna, August 31, 1988. Proceedings.
    Cardiology; 1989; 76 Suppl 2():1-68. PubMed ID: 2766310
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition in the management of congestive heart failure.
    McClure RR
    J Ky Med Assoc; 1988 Jan; 86(1):17-9. PubMed ID: 3278064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Angiotensin I-converting enzyme inhibitors in the treatment of congestive heart failure].
    Correia JF
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():31-6. PubMed ID: 8286140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of cardiac insufficiency with angiotensin-converting enzyme inhibitors].
    Bounhoure JP; Lapeyre G
    Rev Prat; 1988 Mar; 38(10):613-20. PubMed ID: 3375763
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of converting enzyme inhibitors in cardiac failure.
    Ikram H
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):213-4. PubMed ID: 6087049
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition in the 1990s. A symposium of the First International Symposium on Angiotensin Converting Enzyme Inhibition. 14 February 1989, London, UK. Proceedings.
    J Hypertens Suppl; 1989 Sep; 7(5):S1-40. PubMed ID: 2809811
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiotensin converting enzyme inhibitors in the treatment of heart failure].
    Bettencourt P; Ferreira A
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin-converting enzyme inhibition--new methods in the treatment of arterial hypertension and heart failure].
    Scholze J; Linss G; Heublein B
    Z Arztl Fortbild (Jena); 1987; 81(22):1141-50. PubMed ID: 3328434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Should cardiac insufficiency be first treated by angiotensin converting enzyme inhibitors?].
    Bareiss P; Roul G
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():35-40. PubMed ID: 8215788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.